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obtained by the new optimized plans confirm that the EIV 
method can guide optimization and improve plan quality. 
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Purpose or Objective: Pareto fronts are a powerful 
mathematical strategy to formalize the trade-off between a 
given set of mutually contradicting objectives. We use this 
strategy to determine the optimal block margin and 
prescription isodose for both optimal target coverage and 
normal tissue sparing for VMAT treatments in extracranial 
stereotactic radiotherapy. 
 
Material and Methods: Three spherical-shaped targets of 
different dimensions (20cc, 55cc and 101cc) were selected 
from our clinical database. GTV included macroscopic disease 
defined on CT. PTV was defined based on internal margin and 
setup margin. Healthy liver was considered whole liver minus 
GTV. A single fraction dose of 26 Gy was prescribed 
(PD=Prescription Dose). VMAT plans were generated with 
Ergo++ (Elekta) using a 10MV single arc. Pareto fronts based 
on (i) different MLC block margin around PTV (ranging from 
+4mm to -2mm with 1 mm step) and (ii) different 
prescription isodose line (IDS) ranging from 50% to 100% of PD 
were produced. For each block margin, the greatest IDS 
fulfilling the two criteria: 95% of PTV volume reached 100% of 
PD and 90% of PTV reached 99% of PD was considered as that 
providing the optimal clinical plan for target coverage. The 
liver mean dose, V7Gy and V12Gy were used together with 
the PTV coverage (1-V100) to generate the fronts. The ratio 
of the prescription isodose surface volume to PTV volume 
(conformity index CI), gradient index (GI=V50/V100), the 
ratio of normal tissue volume receiving 50% of prescription 
dose and PTV volume (NTV50/PTV), homogeneity index 
(HI=D2%/PD) and healthy liver irradiation in terms of mean 
dose, V7Gy and V12Gy were calculated to compare different 
plans 
 
Results: A total of about 450 plans (150 per lesion) were 
calculated for all block margins and isodose lines. Pareto 
fronts generated for one of the lesions are plotted in figure 
1a,b. For all block margins, PTV coverage is deteriorated 
with the decrease of liver Dmean, V7Gy and V12Gy. The front 
for 1mm MLC margin is situated below and on the left of the 
other fronts for all the three different target sizes. Figure 
1c,d show the GI plotted against the prescribed isodose lines 
and the HI index for the optimal clinical plans. In all cases GI 
shows a U-shaped behavior with minimum values at 1mm for 
all metrics. The location of these minimal points was found 
independent of tumor dimensions. Minimal GI values were 
found at HI values approximately equal to 1.3. Figure 1e and 
1c show the CI and the NTV50/PTV versus HI. With 1mm MLC 
margin the optimal prescription isodose line was found 77-
82% for the three different lesions. 
 
 
 
Conclusion: Pareto fronts provide a rigorous strategy to 
choice clinical optimal plans in SBRT treatments. Our 
evaluation shows that a 1mm MLC block margin provides the 
best results with regard healthy liver tissue irradiation and 
steepness of dose fallout. This choice provided optimal SBRT 
plans at dose prescription to 77%-82% isodose line for all 
target dimensions. 
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Purpose or Objective: Extremity soft tissue sarcomas (ESTS) 
are treated with combined surgery and radiotherapy, 
involving large volumes of healthy tissue. This increases late 
toxicity, which has a negative impact on quality of life. Due 
to the conformal dose distribution of protons a reduction of 
healthy tissue exposure can be expected. The clinical benefit 
in preventing long term toxicity can be fully exploited only if 
the reproducibility and stability of treatment delivery can be 
guaranteed. The aim of our study was to show the feasibility 
and robustness of actively scanned proton therapy with single 
and matched fields. 
 
Material and Methods: In 8 postoperative ESTS patients CTV 
was defined as GTV radially expanded by 1.5cm and 
longitudinally by 4cm. For PTV the CTV was expanded 
isotropically by 1cm [1]. The dose prescription was 60Gy 
(RBE) to D50% of the PTV (2Gy (RBE)/fraction). For treatment 
planning the software Raystation v4.7 (Raysearch 
Laboratories, Sweden) was used. 4/8 patients with PTVs 
longer than 18cm (maximal available field length) required 
field matching. Robust optimization is the method of choice 
in Raystation when two fields with different isocenters are 
